Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Starts Clinical Study of Endurant Evo AAA Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysms

[GlobeNewswire] – Principal Investigators Perform First Implant of Investigational Medical Device Designed to Expand Applicability of Minimally Invasive Alternative to Open Surgical Repair DUBLIN — April 27, 2015 — Medtronic … Read more . . . → Read More: Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Starts Clinical Study of Endurant Evo AAA Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysms Similar Articles: Market Update (NYSE:MDT): Medtronic Acquires Diabeter, Innovative Diabetes Care Provider Company Update (NYSE:MDT): Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Company Update: Medtronic Inc (NYSE:MDT) – Medtronic plans new study of blood pressure-lowering device